1[1]Yeo CJ,Pitt HA,Cameron JL.Cholangiocarcinoma.Surg Clin North Am 1990; 70:1429-1447
2[2]Rossi RL,Heiss FW,Beckmann CF,Braasch JW.Management of cancer of the bile duct.Surg Clin North Am 1985; 65:59-78
3[3]Altemeier WA,Gall EA,Zinninger MM,Hoxworth PI.Sclerosing carcinoma of the major intrahepatic bile ducts.AMA Arch Surg 1957; 75:450-460; discussion 460-461
4[4]Klatskin G.Adenocarcinome of the hepatic duct at its bifucation within the porta hepatic.An unusual tumor with distinctive clinical and pathological features.Am J Med 1965;38:241-256
5[5]Liver cancer study group of Japan.The general rules for the clinical and pathological study of primary liver cancer.Tokyo,Kanehara; 2000
6[6]Yamasaki S.Intrahepatic Cholangiocarcinoma:macroscopic type ahd stage classification.J Hepatobiliary Pancreat Surg 2003;10:288-291
7[7]Pichlmayr R,Weimann A,Klempnauer J,Oldhafer KJ,Maschek H,Tusch G,Ringe B.Surgical treatment in proximal bile duct cancer.A single-center experience.Ann Surg 1996;224:628-638
8[8]Tsao JL Nimura Y,Kamiya J,Hayakawa N,Kondo S,Nagino M,Miyachi M,Kanai M,Uesaka K,Oda K,Rossi RL,Braasch JW,Dugan JM.Management of hilar Cholangiocarcinoma:comparison of an American and a Japanese experience.Ann Surg 2000; 232:166-174
9[9]Bismuth H,Nakache R,Diamond T.Management strategies in resection for hilar Cholangiocarcinoma.Ann Surg 1992; 215:31-38
10[10]Pichlmayr R,Weimann A,Oldhafer KJ,Schlitt HJ,Klempnauer J,Bornscheuer A,Chavan A,Schmoll E,Lang H,Tusch G.Role of liver transplantation in the treatment of unresectable liver cancer.World } Surg 1995; 19:807-813